help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, R. W.
Right arrow Articles by Baird, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, R. W.
Right arrow Articles by Baird, D. T.

Journal of Clinical Endocrinology & Metabolism, Vol 62, 1116-1123, Copyright © 1986 by Endocrine Society


ARTICLES

The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells

RW Kelly, DL Healy, MJ Cameron, IT Cameron and DT Baird

Endometrial stromal cells and isolated endometrial glands obtained from women during days 6-26 of the ovarian cycle were cultured for 24 h in the presence of the progesterone antagonists 17 beta-hydroxy-11 beta-[4- dimethylaminophenyl]17 alpha-[1-propynyl] estra-4,9-dien-3-one (RU486) and 17 beta-hydroxy-11 beta-[4-dimethylaminophenyl] 17 alpha-[3-hydroxy- 1-propenyl]estra-4,9-dien-3-one (ZK 98734). Both steroids stimulated prostaglandin F2 alpha (PGF2 alpha) production by stromal cells in a dose-dependent manner, in doses ranging from 10-1000 nM. Progesterone (100 nM) inhibited RU486 stimulation, except at the highest dose of antiprogestin. PGE2 was produced in smaller amounts than PGF2 alpha, but, when measurable, it also increased in the presence of RU486. In contrast, RU486 did not increase PG production by endometrial glands. In an experiment to determine the effect of pretreatment, stromal cells were incubated for 24 h with 1000 nM progesterone or RU486 (all with 100 nM 17 beta-estradiol) with either 30 or 6 microM arachidonic acid. These six batches of cells were incubated for a second 24 h with either progesterone or antiprogestin. Cells pretreated with the higher dose of arachidonic acid had a marked increase in PGF2 alpha production during the second 24 h only when also pretreated with progesterone. This finding suggests that progesterone allows an accumulation of PG precursor in a suitable accessible pool. Pretreatment with progesterone also allowed a greater conversion of PG to its 13,14-dihydro-15-keto metabolite. These results suggest that antiprogesterone steroids may act as menstrual regulators by: stimulating endogenous PG production within the endometrial stromal cells and inhibiting PG catabolism.


This article has been cited by other articles:


Home page
EndocrinologyHome page
K. C. Jonas, C. Chandras, D. R. E. Abayasekara, and A. E. Michael
Role for Prostaglandins in the Regulation of Type 1 11{beta}-Hydroxysteroid Dehydrogenase in Human Granulosa-Lutein Cells
Endocrinology, December 1, 2006; 147(12): 5865 - 5872.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. K. Hapangama, H. O. D. Critchley, T. A. Henderson, and D. T. Baird
Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5229 - 5234.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P.A. le Roux, S.K. Tregoning, P.M. Zinn, and Z.M. van der Spuy
Inhibition of progesterone secretion with trilostane for mid-trimester termination of pregnancy: randomized controlled trials
Hum. Reprod., June 1, 2002; 17(6): 1483 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
L. Marions and K. G. Danielsson
Expression of cyclo-oxygenase in human endometrium during the implantation period
Mol. Hum. Reprod., October 1, 1999; 5(10): 961 - 965.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. A. Rudolph-Owen, O. D. Slayden, L. M. Matrisian, and R. M. Brenner
Matrix Metalloproteinase Expression in Macaca mulatta Endometrium: Evidence for Zone-Specific Regulatory Tissue Gradients
Biol Reprod, December 1, 1998; 59(6): 1349 - 1359.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
J. D. Graham and C. L. Clarke
Physiological Action of Progesterone in Target Tissues
Endocr. Rev., August 1, 1997; 18(4): 502 - 519.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Fang, S. Wong, and B. F. Mitchell
Effects of RU486 on Estrogen, Progesterone, Oxytocin, and Their Receptors in the Rat Uterus during Late Gestation
Endocrinology, July 1, 1997; 138(7): 2763 - 2768.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. E. Bracken, W. Elger, I. Jantke, A. Nanninga, and B. Gellersen
Cloning of Guinea Pig Cyclooxygenase-2 and 15-Hydroxyprostaglandin Dehydrogenase Complementary Deoxyribonucleic Acids: Steroid-Modulated Gene Expression Correlates to Prostaglandin F2{alpha} Secretion in Cultured Endometrial Cells
Endocrinology, January 1, 1997; 138(1): 237 - 247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society